Search
for
Sort by
Research 211–240 of 579
- Mechanism of PPARα agonist in alopecia areata
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Janus Kinase inhibitors in dermatology: a review
- New therapies for alopecia areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- Treatments for alopecia areata: a network meta-analysis
- Clinical Trials and Hair Loss
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Efficacy of tofacitinib in pediatric alopecia universalis
- Alopecia Areata
- Diagnosis and management of hair loss in children
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Novel drugs of United States Food and Drug Administration approved in 2024
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- The Role of Janus Kinase Inhibitors in Dermatology
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions